ABX Stock Analysis: Abacus Global Management | NYSE
Insurance - Life | NYSE, USA | Market Cap: 858m USD | 12M Return: 46.8% | US00258Y1047 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 4.53M
Qual. Beats: 0
Rev. Trend: 98.0%
Warnings
Tailwinds
No distinct edge detected
Seasonality 6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Abacus Global Management, Inc. (NYSE: ABX) is a U.S.-based alternative asset manager and market maker that operates across three business segments: Asset Management, Life Solutions, and Technology Services. Founded in 2004 and headquartered in Orlando, Florida, the company distributes its offerings through financial advisors, direct-to-consumer channels, and traditional life settlements intermediaries, with operations in the United States, Luxembourg, and other international markets. The firm rebranded from Abacus Life, Inc. to its current name in February 2025 to reflect its broader alternative asset management focus beyond its original life insurance roots.
The Life Solutions segment is the companys core business, acting as an intermediary that connects buyers and sellers in the life settlements market, where existing life insurance policies are sold by original owners to third-party investors. The Asset Management segment manages investments in alternative investment vehicles and exchange-traded funds on behalf of clients, while the Technology Services segment provides contract-based solutions such as real-time mortality verification and missing participant verification, which are specialized back-office services used by insurers, pension funds, and other participants in the life insurance market.
ABX is classified within the Financials sector under the Insurance Brokers sub-industry and trades as a small-cap stock with a market capitalization around $927 million. Its three-segment structure-combining origination of life insurance policy settlements, asset management, and related technology infrastructure-positions it as a vertically integrated participant in the alternative investments and life insurance services space.
- Life settlement origination volume expands across operating segments
- Interest rate shifts impact policy valuation and investment yields
- Asset Management AUM growth drives recurring fee revenue
| Net Income: 28.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 25.64 > 1.0 |
| NWC/Revenue: 12.30% < 20% (prev -21.18%; Δ 33.48% < -1%) |
| CFO/TA 0.10 > 3% & CFO 90.8m > Net Income 28.2m |
| Net Debt (334.6m) to EBITDA (101.1m): 3.31 < 3 |
| Current Ratio: 1.77 > 1.5 & < 3 |
| Outstanding Shares: last quarter (99.8m) vs 12m ago 2.45% < -2% |
| Gross Margin: 68.55% > 18% (prev 88.21%; Δ -19.66% > 0.5%) |
| Asset Turnover: 31.15% > 50% (prev 19.06%; Δ 12.09% > 0%) |
| Interest Coverage Ratio: 2.16 > 6 (EBIT TTM 84.6m / Interest Expense TTM 39.2m) |
| A: 0.04 (Total Current Assets 75.3m - Total Current Liabilities 42.4m) / Total Assets 867.7m |
| B: -0.03 (Retained Earnings -27.9m / Total Assets 867.7m) |
| C: 0.10 (EBIT TTM 84.6m / Avg Total Assets 858.0m) |
| D: 1.03 (Book Value of Equity 439.7m / Total Liabilities 428.1m) |
| Altman-Z'' = 1.88 = BBB |
| DSRI: 1.22 (Receivables 51.9m/25.6m, Revenue 267.3m/161.7m) |
| GMI: 1.29 (GM 88.21% / 68.55%) |
| AQI: 1.03 (AQ_t 0.90 / AQ_t-1 0.87) |
| SGI: 1.65 (Revenue 267.3m / 161.7m) |
| TATA: -0.07 (NI 28.2m - CFO 90.8m) / TA 867.7m) |
| Beneish M = -2.10 (Cap -4..+1) = BB |
As of September 27, 2026, the stock is trading at USD 8.29 with a total of 805,186 shares traded. Over the past week, the price has changed by -5.47%, over one month by -16.09%, over three months by -10.28% and over the past year by +46.82%.
Current recommended Stop Loss: 7.70 (which is 7.1% or 1.3 ATR below the current price).
Abacus Global Management has no consensus analysts rating.
P/E Trailing = 32.4815
P/E Forward = 10.5708
P/S = 3.2087
P/B = 1.973
Revenue TTM = 267.3m USD
EBIT TTM = 84.6m USD
EBITDA TTM = 101.1m USD
Long Term Debt = 290.8m USD (from longTermDebt, last quarter)
Short Term Debt = 42.4m USD (from shortTermDebt, last quarter)
Debt = 358.0m USD (from shortLongTermDebtTotal, last quarter) + Leases 13.7m
Net Debt = 334.6m USD (calculated: Debt 358.0m - CCE 23.4m)
Enterprise Value = 1.19b USD (857.6m + Debt 358.0m - CCE 23.4m)
Interest Coverage Ratio = 2.16 (Ebit TTM 84.6m / Interest Expense TTM 39.2m)
EV/FCF = 13.44x (Enterprise Value 1.19b / FCF TTM 88.7m)
FCF Yield = 7.44% (FCF TTM 88.7m / Enterprise Value 1.19b)
FCF Margin = 33.20% (FCF TTM 88.7m / Revenue TTM 267.3m)
Net Margin = 10.55% (Net Income TTM 28.2m / Revenue TTM 267.3m)
Gross Margin = 68.55% ((Revenue TTM 267.3m - Cost of Revenue TTM 84.1m) / Revenue TTM)
Gross Margin QoQ = 76.73% (prev 76.13%)
Tobins Q-Ratio = 1.37 (Enterprise Value 1.19b / Total Assets 867.7m)
Interest Expense / Debt = 10.95% (Interest Expense 39.2m / Debt 358.0m)
Taxrate = 37.85% (17.2m / 45.4m)
NOPAT = 52.6m (EBIT 84.6m * (1 - 37.85%))
Current Ratio = 1.77 (Total Current Assets 75.3m / Total Current Liabilities 42.4m)
Debt / Equity = 0.81 (Debt 358.0m / totalStockholderEquity, last quarter 439.7m)
Debt / EBITDA = 3.31 (Net Debt 334.6m / EBITDA 101.1m)
Debt / FCF = 3.77 (Net Debt 334.6m / FCF TTM 88.7m)
Total Stockholder Equity = 430.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.29% (Net Income 28.2m / Total Assets 867.7m)
RoE = 6.56% (Net Income TTM 28.2m / Total Stockholder Equity 430.1m)
RoCE = 11.73% (EBIT 84.6m / Capital Employed (Equity 430.1m + L.T.Debt 290.8m))
RoIC = 6.15% (NOPAT 52.6m / Invested Capital 854.4m)
WACC = 7.16% (E(857.6m)/V(1.22b) * Re(7.31%) + D(358.0m)/V(1.22b) * Rd(10.95%) * (1-Tc(0.38)))
Discount Rate = 7.31% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 90.99 | Cagr: 22.64%
[DCF] Terminal Value 75.44% ; FCFF base≈88.7m ; Y1≈89.1m ; Y5≈94.4m
[DCF] Fair Price = 11.59 (EV 1.47b - Net Debt 334.6m = Equity 1.13b / Shares 97.8m; r=8.35% [WACC [floored]]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.20 | # QB: 0
Revenue Correlation: 98.05 | Revenue CAGR: 91.00% | SUE: N/A | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.26 | Chg30d=-2.48% | Revisions=+17% | Analysts=6
EPS current Year (2026-12-31): EPS=1.02 | Chg30d=-1.23% | Revisions=+57% | GrowthEPS=+19.0% | GrowthRev=+21.8%
EPS next Year (2027-12-31): EPS=1.16 | Chg30d=+1.32% | Revisions=+0% | GrowthEPS=+12.9% | GrowthRev=+17.5%
[Analyst] Revisions Ratio: +42% (up=7, down=2)